[Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].

Author: SteinhoffB J, TrinkaE, WendlingA S

Paper Details 
Original Abstract of the Article :
Eslicarbazepine acetate (ESL) was labelled for add-on treatment of adults with focal epilepsies in 2009. ESL is a derivative of carbamazepine and oxcarbazepine (OXC) that promises potentially better effectiveness. It has not yet been investigated how to switch from OXC to ESL and if this switch caus...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00115-010-3177-3

データ提供:米国国立医学図書館(NLM)

Abrupt Switch from Extended-Release Oxcarbazepine to Eslicarbazepine Acetate

This research explores the potential for switching from [extended-release oxcarbazepine (OXC)] to [eslicarbazepine acetate (ESL)] in the treatment of [focal epilepsies]. The authors investigate the feasibility and potential clinical implications of this switch, exploring whether it leads to any significant changes in patient outcomes.

A Potential Shift in Epilepsy Treatment

This research raises interesting questions about the potential for switching from OXC to ESL in the treatment of focal epilepsies. The study's findings provide valuable insights into the feasibility and potential clinical implications of this switch, offering a glimpse into a possible shift in treatment strategies for this complex condition.

Managing Epilepsy with Informed Decisions

If you're being treated for epilepsy, it's crucial to consult with your doctor to discuss the most appropriate treatment plan for your individual needs. This research highlights the potential benefits and challenges of switching between different medications, emphasizing the importance of informed decision-making in managing this complex condition. Remember, the desert of epilepsy can be a challenging landscape, but with the right guidance and support, you can navigate its complexities and find the path to a more comfortable and fulfilling life.

Dr. Camel's Conclusion

This research offers a glimpse into the ever-evolving landscape of epilepsy treatment, exploring the potential for switching from OXC to ESL. It's a reminder that the journey towards effective epilepsy management requires ongoing research, informed decision-making, and a commitment to finding the right approach for each individual. As we continue to explore the vast desert of neurological disorders, we're always seeking new ways to improve patient outcomes and enhance their quality of life. It's a journey that requires patience, persistence, and a belief in the power of scientific progress.

Date :
  1. Date Completed 2012-03-15
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21052972

DOI: Digital Object Identifier

10.1007/s00115-010-3177-3

Related Literature

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.